尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Discover the complete record of transactions filed by Vasconcelles Michael. Director active across 2 companies, notably ImmunoGen, Inc.. In total, 4 disclosures have been published. History available since 29 December 2023. The latest transaction was filed on 29 December 2023 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
VASCONCELLES MICHAEL is a declarant linked to Day One Biopharmaceuticals, Inc. and ImmunoGen, Inc., with 4 filings in total. In the 4 sampled recent filings, the period runs from 2024-01-03 to 2026-04-23, the modal transaction nature is Disposition, and the only amount shown is EUR 19194.88829375556 for ImmunoGen, Inc. on 2024-01-03.